Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047514 · ClinicalTrials.gov registry record · Phase 2
Healthier Living Canada
A Phase 2 study of Asthma and Chronic Disease, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 297
- Enrollment target
- 1
- Study location
NCT01047514: Completed Phase 2 study of Asthma and Chronic Disease, sponsored by Stanford University.
NCT01047514 is a Phase 2 study of Asthma and Chronic Disease that has completed, run by Stanford University. The registered enrollment target is 297 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01047514, a Phase 2 study of Asthma and Chronic Disease, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 297 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of an online Chronic Disease Self-Management Program for participants in Canada living with chronic health conditions. This pilot will look for improvements in health status, health behaviors and health care utilization.
Conditions Studied
Interventions
- BEHAVIORAL Chronic Disease Self-Management Online Workshop
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01047514
The ClinicalTrials.gov registry entry for NCT01047514 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 297 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (81% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Chronic Disease Self-Management Online Workshop is the first listed.
NCT01047514 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01047514 about?
NCT01047514 is a clinical study titled "Healthier Living Canada". This study will evaluate the effectiveness of an online Chronic Disease Self-Management Program for participants in Canada living with chronic health conditions. This pilot will look for improvements in health status, health behaviors and health care utilization.
What is the current status of trial NCT01047514?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 297 participants. The study started on 2010-01. Estimated completion is 2012-08.
What conditions does trial NCT01047514 study?
This clinical trial studies the following conditions: Asthma, Chronic Disease.
What interventions are being tested in trial NCT01047514?
The interventions under investigation include: Chronic Disease Self-Management Online Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT01047514?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01047514 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.